Dr. Van Zeeland joined HLI as part of the acquisition of Cypher Genomics, a leading genome interpretation company, where she was co-founder and CEO. Prior to founding Cypher Genomics, she served as Director, Strategic Partnerships at the Scripps Translational Science Institute where she focused on novel public-private partnerships to accelerate translational research. Before transitioning to her role as Director, Strategic Partnerships she was a research fellow at the Scripps Translational Science Institute working on multiple projects leveraging human genome sequencing to identify disease causative variants and biomarker signatures for various conditions. Dr. Van Zeeland has significant experience leading innovative scientific programs, including groundbreaking work in the genetics of autism, neurodevelopmental disorders and other rare genetic pediatric diseases. She received a Ph.D. in Neuroscience from the University of California, Los Angeles and MBA from the University of California, San Diego.
Pushing the Envelope: Innovative Next-Generation Sequencing Technologies and Applications
1:10 PM - 2:00 PM